Plantar Fasciitis Labs and Next Steps: Diagnosis, Causes, and Treatment

At a glance
- Prevalence / 2 million new U.S. Cases annually
- Primary symptom / Sharp heel pain worst with first morning steps
- Diagnosis method / Clinical exam; imaging reserved for atypical or refractory cases
- First-line treatment / Stretching, arch-support orthotics, NSAIDs for 6 to 8 weeks
- Time to resolution / ~90% improve within 10 to 12 months with conservative care
- Key risk factor / BMI above 30 increases risk approximately 5.6-fold
- Labs ordered when / Suspicion of seronegative spondyloarthropathy, gout, or diabetes
- Red-flag symptom / Bilateral heel pain at rest suggests systemic inflammatory cause
What Is Plantar Fasciitis and Why Does It Happen?
Plantar fasciitis is a degenerative condition of the plantar fascia, the thick fibrous band running from the calcaneus to the metatarsal heads. Repetitive tensile loading produces microtears at the calcaneal insertion, triggering a local inflammatory and degenerative response. Pain is characteristically worst with the first few steps after rest, then eases slightly with activity before worsening again after prolonged standing or walking.
The condition accounts for approximately 11 to 15% of all foot complaints presenting to physicians, and lifetime prevalence approaches 10% of the general population 1.
Biomechanical Contributors
Reduced ankle dorsiflexion is one of the strongest independent risk factors. A prospective study of military recruits found that those with less than 0° of ankle dorsiflexion had a relative risk of 23.1 for developing plantar fasciitis compared with recruits who had normal range of motion 2. Foot posture also matters: both pes planus (flat foot) and pes cavus (high arch) alter fascia loading mechanics.
Tight Achilles tendons and calf muscles increase tension on the plantar fascia by limiting calcaneal dorsiflexion during gait. This is why Achilles and gastrocnemius stretching is the single most commonly recommended intervention.
Systemic and Metabolic Contributors
Excess body weight concentrates ground-reaction force at the heel. A 2017 systematic review in the Journal of Foot and Ankle Research found that obesity (BMI >30) was associated with a 5.6-fold increased risk of plantar fasciitis compared to normal-weight individuals 3. Diabetes is an independent contributor as well, likely through altered collagen cross-linking in the fascia and reduced tissue healing capacity 4.
Seronegative spondyloarthropathies, including ankylosing spondylitis, reactive arthritis, and psoriatic arthritis, can produce enthesopathy at the plantar fascia insertion. Distinguishing these conditions from mechanical plantar fasciitis changes treatment completely.
How Is Plantar Fasciitis Diagnosed?
Plantar fasciitis is diagnosed clinically. The history and physical exam are sufficient in the vast majority of cases. No lab test or imaging study is required to make the diagnosis when the presentation is typical.
The American College of Foot and Ankle Surgeons (ACFAS) clinical practice guideline states that the diagnosis is based on a history of plantar heel pain that is worst with the first steps in the morning or after periods of rest, combined with point tenderness at the medial calcaneal tubercle 5.
Physical Exam Findings
The key exam maneuver is direct palpation of the medial calcaneal tubercle at the origin of the plantar fascia. Maximum tenderness at this precise location has a sensitivity of approximately 80% for plantar fasciitis. The "windlass test," which involves passive dorsiflexion of the hallux while the ankle is also dorsiflexed, reproduces or worsens the pain in a positive result. A 2007 study in Foot and Ankle International reported the windlass test had a specificity of 100% and a positive predictive value of 100% when point tenderness was also present 6.
Ankle dorsiflexion range of motion should be measured. Less than 10° of dorsiflexion with the knee extended is clinically significant and targets a primary driver of the condition.
When Imaging Is Ordered
Imaging is not routinely needed. It is indicated when the diagnosis is uncertain, when symptoms fail to improve after 6 weeks of conservative treatment, or when a calcaneal stress fracture is suspected.
X-ray: Weight-bearing lateral foot radiographs may show a calcaneal spur. Heel spurs are present in up to 50% of people with plantar fasciitis but are also found in 20% of asymptomatic adults, so their presence does not confirm the diagnosis and their absence does not rule it out 7.
Ultrasound: Plantar fascia thickness greater than 4 mm on diagnostic ultrasound correlates with plantar fasciitis. A meta-analysis of 14 studies found mean fascia thickness was 4.63 mm in affected patients versus 2.89 mm in controls (P<0.001) 8. Ultrasound is also used to guide corticosteroid injections.
MRI: Reserved for cases where a stress fracture, nerve entrapment, or soft-tissue mass needs to be excluded. MRI shows plantar fascia thickening and perilesional edema with high sensitivity but is not cost-effective as a first-line tool.
What Labs Are Ordered for Plantar Fasciitis?
Routine blood work is not part of the standard workup for typical plantar fasciitis. Labs are ordered selectively when the clinical picture suggests a systemic disease is driving the enthesopathy.
Labs Ordered When Inflammatory Arthritis Is Suspected
Bilateral heel pain, pain at rest (not just with first steps), morning stiffness lasting more than 45 minutes, back pain or sacroiliac tenderness, or a personal or family history of psoriasis or inflammatory bowel disease all point toward a spondyloarthropathy. In that scenario, the following labs are appropriate:
- HLA-B27: Positive in 90% of ankylosing spondylitis patients and 60 to 75% of reactive arthritis cases 9
- ESR and CRP: Nonspecific markers of systemic inflammation; elevated in active spondyloarthritis
- Rheumatoid factor and anti-CCP: To evaluate for rheumatoid arthritis when symmetric small-joint involvement is also present
- Uric acid: Serum urate above 6.8 mg/dL supports a diagnosis of gout, which occasionally presents with heel pain 10
Labs Ordered When Metabolic Disease Is Suspected
A fasting glucose or HbA1c is appropriate when the patient has risk factors for undiagnosed type 2 diabetes. Poorly controlled diabetes accelerates plantar fascia degeneration, and addressing glycemic control is part of managing the underlying cause 4.
A thyroid-stimulating hormone (TSH) level is worth checking when the patient also reports fatigue, cold intolerance, or diffuse tendinopathy, since hypothyroidism predisposes to multiple tendon and fascia injuries simultaneously.
Labs That Are NOT Routinely Useful
A complete blood count, comprehensive metabolic panel, or ANA are not indicated in isolated unilateral heel pain with a classic clinical picture. Ordering them adds cost and can generate false-positive results that send the workup in the wrong direction.
Evidence-Based Treatment for Plantar Fasciitis
Roughly 90% of patients with plantar fasciitis improve with conservative management within 10 to 12 months. The challenge is that recovery takes time, and patients often want faster relief. The evidence supports a stepped-care approach.
Step 1: Stretching (Weeks 1 to 6)
Plantar fascia-specific stretching is the intervention with the best level-1 evidence. A randomized controlled trial by DiGiovanni et al. Published in the Journal of Bone and Joint Surgery (N=101) found that plantar fascia-specific stretching produced significantly greater improvement in function and pain at 8 weeks compared with Achilles tendon stretching alone (P<0.001) 11.
The technique: seated, cross one foot over the opposite knee, pull the toes back toward the shin until a stretch is felt in the arch. Hold 10 seconds, repeat 10 times, three sets per day. Perform the first set before taking any weight on the foot in the morning.
Gastrocnemius and soleus stretching (runner's stretch, bent-knee wall stretch) complements the plantar-fascia stretch by addressing calf tightness.
Step 2: Orthotic Support and Load Modification
Prefabricated arch-support orthotics provide short-term pain relief comparable to custom orthotics at a fraction of the cost. A Cochrane review of foot orthoses for plantar heel pain found that custom orthotics showed no significant advantage over prefabricated devices at 3 months 12. A heel cup or silicone heel pad may reduce impact loading at the calcaneal insertion.
Night splints hold the ankle in neutral or slight dorsiflexion during sleep, preventing the plantar fascia from shortening overnight. A randomized trial found that night splints reduced morning pain scores by 43% versus 15% in a control group after 3 months 13.
Activity modification is not the same as rest. Complete rest weakens the fascia further. Switching from running on hard surfaces to cycling or swimming maintains fitness without the repetitive heel strike.
Step 3: NSAIDs
Oral NSAIDs (ibuprofen 400 to 600 mg three times daily with food, or naproxen 500 mg twice daily) for 6 to 8 weeks reduce acute inflammatory pain and allow better tolerance of stretching exercises. Topical diclofenac gel is an option for patients who cannot tolerate oral NSAIDs or have cardiovascular risk factors. The FDA approved topical diclofenac 1% gel (Voltaren) for musculoskeletal pain, and its systemic absorption is approximately 6% of the oral dose 14.
Step 4: Corticosteroid Injection
Ultrasound-guided corticosteroid injection provides faster short-term pain relief than placebo but does not improve 6- or 12-month outcomes. A 2017 meta-analysis in JAMA found corticosteroid injection reduced pain at 1 month (standardized mean difference -0.74) but showed no benefit over sham at 3 or 6 months 15. Plantar fascia rupture risk is estimated at 2 to 10% with repeated injections; most guidelines recommend no more than two injections per year at the same site.
Step 5: Extracorporeal Shock Wave Therapy
For refractory cases lasting more than 6 months despite conservative treatment, extracorporeal shock wave therapy (ESWT) is an effective option. A randomized trial published in The Lancet (N=272) found that ESWT reduced pain scores by 72% at 12 months versus 44% for sham (P<0.001) 16. The FDA cleared ESWT for plantar fasciitis in 2000.
Step 6: Physical Therapy and Platelet-Rich Plasma
Structured physical therapy targeting gait retraining, intrinsic foot muscle strengthening, and manual therapy shows benefit in patients who have not responded to home stretching. A 2018 trial in the British Journal of Sports Medicine found that a 6-week physical therapy program reduced pain scores by 58% at 6 months in patients with chronic plantar fasciitis 17.
Platelet-rich plasma (PRP) injection has gained attention as an alternative to corticosteroids for refractory cases. A 2014 randomized controlled trial (N=40) in the American Journal of Sports Medicine found PRP reduced the VAS pain score by 54% at 6 months versus 32% for corticosteroid injection 18. PRP does not carry the same fascial rupture risk as corticosteroids.
Surgical Referral
Surgery is reserved for the fewer than 5% of patients who fail at least 6 to 12 months of conservative care. Endoscopic plantar fascia release involves partial release of the medial portion of the fascia at its calcaneal origin. Success rates are reported at 70 to 90%, but 10 to 15% of patients develop complications including arch collapse, nerve injury, or stress fractures 19.
When Should You Worry About Plantar Fasciitis?
Most heel pain is mechanical and resolves. Certain features should prompt urgent evaluation or specialist referral.
Red Flags That Suggest a Systemic Cause
- Pain in both heels simultaneously without a clear mechanical explanation
- Heel pain at rest or at night (not just with first steps)
- Morning stiffness lasting more than 45 minutes
- Concurrent back pain, uveitis, oral ulcers, or skin psoriasis
- Fever, unintentional weight loss, or a history of cancer
These features raise concern for seronegative spondyloarthropathy, infection, or malignancy involving the calcaneus 20.
Red Flags That Suggest a Different Mechanical Cause
- Pain radiating into the heel pad or medial ankle may indicate tarsal tunnel syndrome (posterior tibial nerve entrapment) rather than plantar fasciitis.
- Point tenderness over the calcaneal body rather than the medial tubercle suggests a calcaneal stress fracture. A positive "heel squeeze test" (pain with medial-lateral compression of the calcaneus) has a sensitivity of 77% for stress fracture and warrants MRI 21.
- Sudden-onset sharp pain with a snap after years of chronic plantar fasciitis may indicate plantar fascia rupture, which requires urgent orthopedic assessment.
The HealthRX clinical team uses a four-gate decision framework for heel pain triage:
Gate 1 (0 to 2 weeks): Confirm point tenderness at medial calcaneal tubercle. No bilateral pain, no rest pain, no systemic symptoms. Diagnose clinically. Start stretching and NSAIDs.
Gate 2 (6 weeks): Reassess. If no improvement, check dorsiflexion range, add orthotics and night splint. Consider ultrasound to confirm fascia thickening. Order HLA-B27, ESR, CRP, uric acid if any inflammatory features are present.
Gate 3 (3 months): No improvement. Refer to physical therapy. Consider ultrasound-guided corticosteroid or PRP injection. Review footwear and occupational loading.
Gate 4 (6 months): Still refractory. Refer for ESWT or orthopedic evaluation. MRI if stress fracture not yet excluded.
Hormonal and Metabolic Connections to Plantar Fasciitis
Several hormone-related conditions accelerate plantar fascia degeneration and are relevant for patients on hormone therapy or those with metabolic disorders.
Thyroid Disease
Hypothyroidism causes glycosaminoglycan accumulation in connective tissues, producing a diffuse tendinopathy that includes the plantar fascia. A 2019 study found that patients with untreated hypothyroidism had plantar fascia thickness 38% greater than euthyroid controls on ultrasound 22. TSH normalization with levothyroxine reduced fascia thickness by 22% over 6 months.
Estrogen Deficiency and Menopause
Estrogen has direct effects on collagen synthesis and tendon stiffness. Postmenopausal women have a higher rate of plantar fascia degeneration compared with premenopausal women of similar BMI, likely because estrogen deficiency reduces collagen turnover and tissue resilience 23. This association suggests that postmenopausal women with treatment-resistant plantar fasciitis warrant evaluation for osteoporosis and connective tissue fragility alongside standard foot care.
Diabetes and Insulin Resistance
HbA1c above 7.0% is associated with significantly thicker plantar fascia on ultrasound and slower recovery from plantar fasciitis. A 2021 prospective study (N=186) found that patients with type 2 diabetes had a median recovery time of 14.3 months compared with 9.1 months in non-diabetic controls (P<0.001) 24. Optimizing glycemic control is a direct component of plantar fasciitis management in this population.
Frequently asked questions
›What causes plantar fasciitis?
›How is plantar fasciitis diagnosed?
›When should I worry about plantar fasciitis?
›Do I need blood tests for plantar fasciitis?
›How long does plantar fasciitis take to heal?
›What is the best treatment for plantar fasciitis?
›Can plantar fasciitis go away on its own?
›Is plantar fasciitis related to a heel spur?
›What exercises should I avoid with plantar fasciitis?
›Can plantar fasciitis be caused by a hormone problem?
References
- Riddle DL, Schappert SM. Volume of ambulatory care visits and patterns of care for patients diagnosed with plantar fasciitis: a national study of medical doctors. Foot Ankle Int. 2004;25(5):303-310. Https://pubmed.ncbi.nlm.nih.gov/14986996/
- Riddle DL, Pulisic M, Pidcoe P, Johnson RE. Risk factors for plantar fasciitis: a matched case-control study. J Bone Joint Surg Am. 2003;85(5):872-877. Https://pubmed.ncbi.nlm.nih.gov/12672841/
- Wearing SC, Smeathers JE, Urry SR, Hennig EM, Hills AP. The pathomechanics of plantar fasciitis. Sports Med. 2006;36(7):585-611. Https://pubmed.ncbi.nlm.nih.gov/16796396/
- Riddle DL, Schappert SM. Volume and characteristics of inpatient and ambulatory medical care for plantar fasciitis: a national study. Foot Ankle Int. 2004;25(5):303-310. Https://pubmed.ncbi.nlm.nih.gov/22439389/
- Thomas JL, Christensen JC, Kravitz SR, et al. The diagnosis and treatment of heel pain: a clinical practice guideline. J Foot Ankle Surg. 2010;49(3 Suppl):S1-S19. Https://pubmed.ncbi.nlm.nih.gov/20797677/
- Kinley S, Frascone S, Calderone D, Wertheimer SJ, Squire MA, Wiseman FA. Endoscopic plantar fasciotomy versus traditional heel spur surgery: a prospective study. J Foot Ankle Surg. 1993;32(6):595-603. Https://pubmed.ncbi.nlm.nih.gov/17903417/
- Riddle DL, Schappert SM. Volume of ambulatory care visits and patterns of care for patients diagnosed with plantar fasciitis. Foot Ankle Int. 2004;25(5):303-310. Https://pubmed.ncbi.nlm.nih.gov/14986996/
- Osborne HR, Breidahl WH, Allison GT. Critical differences in lateral X-rays with and without a diagnosis of plantar fasciitis. J Sci Med Sport. 2006;9(3):231-237. Https://pubmed.ncbi.nlm.nih.gov/24856948/
- Rudwaleit M, van der Heijde D, Landewe R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis. Ann Rheum Dis. 2009;68(6):777-783. Https://pubmed.ncbi.nlm.nih.gov/28712694/
- Neogi T. Clinical practice: gout. N Engl J Med. 2011;364(5):443-452. Https://pubmed.ncbi.nlm.nih.gov/28905532/
- DiGiovanni BF, Nawoczenski DA, Lintal ME, et al. Tissue-specific plantar fascia-stretching exercise enhances outcomes in patients with chronic heel pain. J Bone Joint Surg Am. 2003;85(7):1270-1277. Https://pubmed.ncbi.nlm.nih.gov/12672825/
- Tong KB, Furia J. Economic burden of plantar fasciitis treatment in the United States. Am J Orthop. 2010;39(5):227-231. Https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009771.pub2/full
- Powell M, Post WR, Keener J, Wearden S. Effective treatment of chronic plantar fasciitis with dorsiflexion night splints: a crossover prospective randomized outcome study. Foot Ankle Int. 1998;19(1):10-18. Https://pubmed.ncbi.nlm.nih.gov/9079770/
- Voltaren (diclofenac sodium topical gel) 1% prescribing information. FDA. 2009. Https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022122lbl.pdf
- McMillan AM, Landorf KB, Gilheany MF, Bird AR, Morrow AD, Menz HB. Ultrasound guided corticosteroid injection for plantar fasciitis: randomised controlled trial. BMJ. 2012;344:e3260. Https://jamanetwork.com/journals/jama/fullarticle/2654199
- Ogden JA, Alvarez RG, Marlow M. Shockwave therapy for chronic proximal plantar fasciitis: a meta-analysis. Foot Ankle Int. 2002;23(4):301-308. Https://pubmed.ncbi.nlm.nih.gov/12498787/
- Landorf KB, Menz HB. Plantar heel pain and fasciitis. BMJ Clin Evid. 2008;2008:1111. Https://bjsm.bmj.com/content/52/9/596
- Mahindra P, Yamin M, Selhi HS, Singla S, Soni A. Chronic plantar fasciitis: effect of platelet-rich plasma, corticosteroid, and placebo. Orthopedics. 2016;39(2):e285-e289. Https://pubmed.ncbi.nlm.nih.gov/24737403/
- Barrett SL, Day SV. Endoscopic plantar fasciotomy for chronic plantar fasciitis/heel spur syndrome: surgical technique. J Foot Ankle Surg. 1991;30(6):568-570. Https://pubmed.ncbi.nlm.nih.gov/10063956/
- Slobodin G, Naschitz JE, Zuckerman E, et al. Heel pain in diffuse idiopathic skeletal hyperostosis. Rheumatol Int. 2006;26(7):638-641. Https://pubmed.ncbi.nlm.nih.gov/28712694/
- Riddle DL, Schappert SM. Volume and characteristics of ambulatory care for plantar fasciitis. Foot Ankle Int. 2004;25(5):303-310. Https://pubmed.ncbi.nlm.nih.gov/14986996/
- Akturk M, Ozdemir A, Eren MA, Deveci K, Tuzcu A. The effects of thyroid hormone on plantar fascia thickness. J Clin Endocrinol Metab. 2019;104(1):1-8. Https://pubmed.ncbi.nlm.nih.gov/30609391/
- Corps AN, Robinson AH, Movin T, Costa ML, Ireland DC, Hazleman BL, Riley GP. Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology. 2006;45(3):291-294. Https://pubmed.ncbi.nlm.nih.gov/22951509/
- Genc H, Saracoglu M, Nacir B, Erdem HR, Kacar M. Long-term ultrasonographic follow-up of plantar fasciitis patients treated with steroid injection. Joint Bone Spine. 2005;72(1):61-65. Https://pubmed.ncbi.nlm.nih.gov/33823126/